US moves to soften capital rules: ‘Big banks can declare mission accomplished’

Fed officials are expected to vote to lower bank capital requirements by 4.8% for the largest banks, 5.2% for larger regional banks and 7.7% for banks under $100B, freeing up regulatory capital for firms like JPMorgan, Goldman Sachs and Morgan Stanley. The change, driven by Fed supervisor Michelle Bowman and representing a major revision to Basel III, is likely to boost bank shareholder returns but has drawn political criticism (Elizabeth Warren) over increased systemic risk and potential reduced lending to small businesses.

Analysis

The regulatory recalibration materially changes the trade-off between capital retention and shareholder distributions: marginal capital freed is likely to flow to buybacks/dividends and higher-risk origination rather than new branches or balance-sheet insulation. For large, capital-light franchises (market-making, FICC, advisory) this is a levered EPS kicker — model conservatively implies 5–10% upside to EPS for megabanks within 12 months if ~50–70% of freed capital returns to buybacks, and a further 100–300bp uplift to reported ROE if leverage increases on the margin.

Competitive dynamics will bifurcate: scale players win (lower incremental capital cost on large RWA books and trading inventories), while smaller lenders and specialty credit providers lose pricing power and see deposit flows pressuring NIMs as megabanks redeploy capital into targeted origination and cross-sell. Expect accelerated product commoditization in corporate lending and payment services; fintechs and non-bank lenders may be squeezed on pricing but could pick up niche market share where banks retreat from consumer credit.

Key risks are political/legal pushback and macro shocks that re-price credit risk — both can prompt rapid reversal of regulatory goodwill and force re-capitalization. Near-term catalysts: next 3–6 month capital plans, upcoming stress-test results, and large-bank buyback filings; medium-term (12–24 months) risk is a regulatory pivot after an adverse event or election-driven oversight change which can erase the valuation uplift quickly.

Key Decisions for Investors

• Long JPM outright (size: 1–2% NAV) into the next 1–3 months on expected buyback/dividend reallocation; target 12-month total return +15–25% vs downside limited to -20% if a regulatory reversal occurs. Hedge with 2–3% NAV of OTM 9–12 month puts (strike ~85% spot) to cap tail risk.
• Long GS (size: 1% NAV) via Jan 2027 calls (buy 12–18 month expiries, ~10–15% OTM) to capture optionality from capital-light FICC/IB earnings leverage; breakeven if returns to buybacks hit ~5–7% EPS accretion. Sell shorter-dated covered calls (2–3 months) to monetize elevated near-term implied volatility.
• Relative pair: long GS / short regional bank ETF (e.g., KRE) for 6–12 months; expected asymmetry: GS captures buyback-driven EPS and trading upside while regionals face margin compression and competitive deposit pricing. Size 1:1 notional, monitor for policy headlines — unwind on sustained widening of regional spreads >150bp.
• Event hedge: buy protection on bank-system stress (CDS index or 6–12 month bank equity puts) sized to cover 3–5% NAV — cost acceptable vs asymmetric upside from capital returns but essential if political/regulatory reversal or credit shock emerges within 12 months.